151 related articles for article (PubMed ID: 25446760)
1. The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserine.
Philbert J; Beeské S; Belzung C; Griebel G
Behav Brain Res; 2015 Feb; 279():41-6. PubMed ID: 25446760
[TBL] [Abstract][Full Text] [Related]
2. The CRF₁ receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: comparison with paroxetine and D-cycloserine.
Philbert J; Belzung C; Griebel G
Psychopharmacology (Berl); 2013 Jul; 228(1):97-107. PubMed ID: 23407783
[TBL] [Abstract][Full Text] [Related]
3. The CRF₁ receptor antagonist SSR125543 attenuates long-term cognitive deficit induced by acute inescapable stress in mice, independently from the hypothalamic pituitary adrenal axis.
Philbert J; Pichat P; Palme R; Belzung C; Griebel G
Pharmacol Biochem Behav; 2012 Sep; 102(3):415-22. PubMed ID: 22659580
[TBL] [Abstract][Full Text] [Related]
4. Acute inescapable stress exposure induces long-term sleep disturbances and avoidance behavior: a mouse model of post-traumatic stress disorder (PTSD).
Philbert J; Pichat P; Beeské S; Decobert M; Belzung C; Griebel G
Behav Brain Res; 2011 Aug; 221(1):149-54. PubMed ID: 21377492
[TBL] [Abstract][Full Text] [Related]
5. The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in mice.
Urani A; Philbert J; Cohen C; Griebel G
Pharmacol Biochem Behav; 2011 May; 98(3):425-31. PubMed ID: 21356230
[TBL] [Abstract][Full Text] [Related]
6. A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances.
Nedelcovych MT; Gould RW; Zhan X; Bubser M; Gong X; Grannan M; Thompson AT; Ivarsson M; Lindsley CW; Conn PJ; Jones CK
ACS Chem Neurosci; 2015 Mar; 6(3):485-93. PubMed ID: 25581551
[TBL] [Abstract][Full Text] [Related]
7. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
Doyon C; Samson P; Lalonde J; Richard D
J Endocrinol; 2007 Apr; 193(1):11-9. PubMed ID: 17400798
[TBL] [Abstract][Full Text] [Related]
8. Effects of urocortin, corticotropin-releasing factor (CRF) receptor agonist, and astressin, CRF receptor antagonist, on the sleep-wake pattern: analysis by radiotelemetry in conscious rats.
Uchida M; Suzuki M; Shimizu K
Biol Pharm Bull; 2007 Oct; 30(10):1895-7. PubMed ID: 17917258
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat.
Louis C; Cohen C; Depoortère R; Griebel G
Neuropsychopharmacology; 2006 Oct; 31(10):2180-7. PubMed ID: 16452986
[TBL] [Abstract][Full Text] [Related]
10. Non-selective orexin-receptor antagonist attenuates stress-re-stress-induced core PTSD-like symptoms in rats: Behavioural and neurochemical analyses.
Prajapati SK; Krishnamurthy S
Behav Brain Res; 2021 Feb; 399():113015. PubMed ID: 33212086
[TBL] [Abstract][Full Text] [Related]
11. R278995/CRA0450, a corticotropin-releasing factor (CRF(1)) receptor antagonist modulates REM sleep measures in rats: Implication for therapeutic indication.
Ahnaou A; Steckler T; Heylen A; Kennis L; Nakazato A; Chaki S; Drinkenburg WH
Eur J Pharmacol; 2012 Apr; 680(1-3):63-8. PubMed ID: 22314225
[TBL] [Abstract][Full Text] [Related]
12. Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice.
Kantor S; Varga J; Kulkarni S; Morton AJ
Neurotherapeutics; 2017 Oct; 14(4):1120-1133. PubMed ID: 28653279
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression.
Overstreet DH; Griebel G
Eur J Pharmacol; 2004 Aug; 497(1):49-53. PubMed ID: 15321734
[TBL] [Abstract][Full Text] [Related]
14. Deep brain stimulation in treatment-resistant depression in mice: comparison with the CRF1 antagonist, SSR125543.
Dournes C; Beeské S; Belzung C; Griebel G
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():213-20. PubMed ID: 23367508
[TBL] [Abstract][Full Text] [Related]
15. Severe and protracted sleep disruptions in mouse model of post-traumatic stress disorder.
Sharma R; Sahota P; Thakkar MM
Sleep; 2018 Mar; 41(3):. PubMed ID: 29346627
[TBL] [Abstract][Full Text] [Related]
16. The α1 adrenoceptor antagonist prazosin enhances sleep continuity in fear-conditioned Wistar-Kyoto rats.
Laitman BM; Gajewski ND; Mann GL; Kubin L; Morrison AR; Ross RJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():7-15. PubMed ID: 24246572
[TBL] [Abstract][Full Text] [Related]
17. Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat.
Claustre Y; Rouquier L; Desvignes C; Leonetti M; Montégut J; Aubin N; Allouard N; Bougault I; Oury-Donat F; Steinberg R
Neuroscience; 2006 Sep; 141(3):1481-8. PubMed ID: 16781820
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine regulation of sleep disturbances in PTSD.
Neylan TC; Otte C; Yehuda R; Marmar CR
Ann N Y Acad Sci; 2006 Jul; 1071():203-15. PubMed ID: 16891571
[TBL] [Abstract][Full Text] [Related]
19. Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD.
Yamamoto S; Morinobu S; Fuchikami M; Kurata A; Kozuru T; Yamawaki S
Neuropsychopharmacology; 2008 Aug; 33(9):2108-16. PubMed ID: 17957211
[TBL] [Abstract][Full Text] [Related]
20. Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats.
Knapp DJ; Overstreet DH; Huang M; Wills TA; Whitman BA; Angel RA; Sinnett SE; Breese GR
Psychopharmacology (Berl); 2011 Nov; 218(1):179-89. PubMed ID: 21643675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
